Prevalence of the metabolic syndrome among Italian adults according to ATP III definition

被引:168
作者
Miccoli, R
Bianchi, C
Odoguardi, L
Penno, G
Caricato, F
Giovannitti, MG
Pucci, L
Del Prato, S
机构
[1] Univ Pisa, Dept Endocrinol & Metab, Pisa, Italy
[2] Osped Lucca, Div Cardiol, Lucca, Italy
关键词
metabolic syndrome; insulin resistance; cardiovascular disease;
D O I
10.1016/j.numecd.2004.09.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim: To evaluate the prevalence of the metabolic syndrome as defined by NCEP ATP III criteria in an Italian cohort of adult subjects. Methods and results: A total of 2100 subjects aged 19 years or more, were randomly selected from the general population of the Lucca area. Metabolic syndrome was defined by the clustering of three or more of the following abnormalities: waist circumference greater than 102 cm in men and 88 cm in women; serum triglycerides level of at least 150 mg/dl (1.69 mmol/l); high-density lipoprotein cholesterol less than 40 mg/dl (1.04 mmol/l) in men and 50 mg/dl (1.29 mmol/l) in women; blood pressure greater than 130/85 mmHg; or serum glucose greater than 110 mg/dl (6.1 mmol/l). The prevalence of the metabolic syndrome was 18% in women and 15% in men. The prevalence increased from 3% among subjects aged 20-29 years to 25% in subjects aged 70 years or older. Application of this estimated prevalence data to the Italian adult population suggests that 3.6 million women and 3 million men may have the metabolic syndrome. Conclusions: The prevalence of metabolic syndrome in a cohort likely representative of the Italian adult population is high. The recognition of the syndrome may represent an important challenge for physicians and healthcare and requires immediate strategies aimed to reduce level of individual metabolic traits. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:250 / 254
页数:5
相关论文
共 31 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]  
[Anonymous], 2001, GUID DOC US IN VITR
[4]  
[Anonymous], 1996, Physical activity and health: A report of the Surgeon General
[5]  
Balkau B, 1999, DIABETIC MED, V16, P442
[6]   Metabolic Syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study [J].
Bonora, E ;
Kiechl, S ;
Willeit, J ;
Oberhollenzer, F ;
Egger, G ;
Bonadonna, RC ;
Muggeo, M .
INTERNATIONAL JOURNAL OF OBESITY, 2003, 27 (10) :1283-1289
[7]   Carotid atherosclerosis and coronary heart disease in the metabolic syndrome - Prospective data from the Bruneck Study [J].
Bonora, E ;
Kiechl, S ;
Willeit, J ;
Oberhollenzer, F ;
Egger, G ;
Bonadonna, RC ;
Muggeo, M .
DIABETES CARE, 2003, 26 (04) :1251-1257
[8]  
*BRIT HEART FDN, 2004, BRIT HEART FDN COR H, pCH11
[9]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[10]  
DESCOVICH GC, 1993, PLURIMETABOLIC SYNDR, P67